Gross profit increased 35.7%
Gross profit changed +35.7% from the comparable as-filed period.
$6.1M→$8.3M3 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →JRSH financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Gross margin moved 108 bp higher
Gross margin changed +108 basis points from the comparable as-filed period.
15.36%→16.45%3 prior comparisons
Operating cash flow changed across a sign change
Operating cash flow changed +139.1% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
-$6.5M→$2.5M3 prior comparisons
Trade receivables decreased 40.9%
Trade receivables changed -40.9% from the comparable as-filed period.
$10.0M→$5.9M3 prior comparisons
Operating cash-flow margin moved 2139 bp higher
Operating cash-flow margin changed +2139 basis points from the comparable as-filed period.
-16.35%→5.04%3 prior comparisons
Capital expenditure decreased 60.3%
Capital expenditure changed -60.3% from the comparable as-filed period.
$464,890→$184,6063 prior comparisons
Receivables / revenue moved 1344 bp lower
Receivables / revenue changed -1344 basis points from the comparable as-filed period.
25.18%→11.74%3 prior comparisons
Working capital / assets moved 127 bp higher
Working capital / assets changed +127 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
42.34%→43.61%3 prior comparisons
Total assets increased 6.9%
Total assets changed +6.9% from the comparable as-filed period.
$81.7M→$87.4M3 prior comparisons
Current ratio increased 9.3%
Current ratio changed +9.3% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
2.85→3.113 prior comparisons
Working capital increased 10.1%
Working capital changed +10.1% from the comparable as-filed period.
$34.6M→$38.1M3 prior comparisons
Current liabilities decreased 3.7%
Current liabilities changed -3.7% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$18.8M→$18.1M3 prior comparisons
Capex / revenue moved 81 bp lower
Capex / revenue changed -81 basis points from the comparable as-filed period.
1.17%→0.37%3 prior comparisons
Current assets increased 5.2%
Current assets changed +5.2% from the comparable as-filed period.
$53.4M→$56.2M3 prior comparisons
Inventory decreased 2.6%
Inventory changed -2.6% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$27.3M→$26.6M3 prior comparisons
Stockholders' equity increased 5.2%
Stockholders' equity changed +5.2% from the comparable as-filed period.
$62.7M→$66.0M2 prior comparisons
Selling, general & administrative increased 10.1%
Selling, general & administrative changed +10.1% from the comparable as-filed period.
$4.9M→$5.4M3 prior comparisons
Shares outstanding unchangedd 0.0%
Shares outstanding changed +0.0% from the comparable as-filed period. The change ranks at the 43th percentile of 7 prior comparable changes.
12,699,940→12,699,9407 prior comparisons
SBC / revenue moved 11 bp lower
SBC / revenue changed -11 basis points from the comparable as-filed period.
0.56%→0.45%3 prior comparisons
Operating cash flow / net income changed across a sign change
Operating cash flow / net income changed +107.4% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
-20.33→1.510 prior comparisons
Stock-based compensation increased 1.6%
Stock-based compensation changed +1.6% from the comparable as-filed period.
$222,669→$226,3383 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.